Three-Year Durability of Dual-Nucleoside Versus Triple-Nucleoside Therapy in a Thai Population With HIV Infection

Type de record:

paper

Créateur:

ChaPrePetKia

Éditeur:

Ovi

Hôte:

Visit

Similaires

Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in MalawiDynamics and drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors in nine African countries<i>In Silico</i> Investigation of Flavonoids as Potential Trypanosomal Nucleoside Hydrolase InhibitorsPersons living with HIV infection on antiretroviral therapy also consulting traditional healers: a study in three African countriesCharacterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected IndividualsDurability of second-line anti-retroviral therapy in a resource-limited setting: an 11-year analytical cohort

Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi

Background Information on HIV drug resistance (HIVDR) prevalence in people new

Dynamics and drivers of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors in nine African countries

Background. The rise of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (NN

<i>In Silico</i> Investigation of Flavonoids as Potential Trypanosomal Nucleoside Hydrolase Inhibitors

Human African Trypanosomiasis is endemic to 37 countries of sub-Saharan Africa. It is caused by two

Persons living with HIV infection on antiretroviral therapy also consulting traditional healers: a study in three African countries

Traditional healers provide healthcare to a substantial proportion of people living with HIV infecti

Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals

The South African national treatment programme includes nucleoside reverse transcriptase inhibitors

Durability of second-line anti-retroviral therapy in a resource-limited setting: an 11-year analytical cohort

ABSTRACT Background It is projected that u